As NLRP3 is likely to be critically involved in OSCC occurrence, progression, and proliferation, few studies have shed light on possible strategies for oral cancer treatment, regarding the NLRP3-inflammasome. This evidence concerns the gene NLRP3 and lip and oral cavity carcinoma.